BIOTECHNOLOGY VALUE FUND L P 13D/13G Filings for GlycoMimetics, Inc. (GLYC)

BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for GlycoMimetics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		Transaction
Date		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportView
2024-01-29
4:31 pm
Unchanged		2023-03-2913GGlycoMimetics, Inc.
GLYC		BIOTECHNOLOGY VALUE FUND L P95,443
14.800%		0
(Unchanged)		Filing
2021-02-11
5:14 pm
Purchase		2020-12-3113GGlycoMimetics, Inc.
GLYC		BIOTECHNOLOGY VALUE FUND L P95,443
19.960%		21,825increase
(+29.65%)		Filing